This trial is testing whether a new ultrasound guidance and monitoring system is effective for treating early stage breast cancer.
4 Primary · 0 Secondary · Reporting Duration: From the date of ablation and imaging to the date of pathological results (approximately 1 week)
Experimental Treatment
36 Total Participants · 1 Treatment Group
Primary Treatment: Harmonic motion imaging guided focused ultrasound (HMIgFUS) · No Placebo Group · N/A
Age 18+ · Female Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: